We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$712B
AUM Growth
+$31.8B
Cap. Flow
+$2.48B
Cap. Flow %
0.35%
Top 10 Hldgs %
21.18%
Holding
2,600
New
72
Increased
1,394
Reduced
949
Closed
59

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.27B
2
LLY icon
Eli Lilly
LLY
+$1.64B
3
NVDA icon
NVIDIA
NVDA
+$1.59B
4
RHT
Red Hat Inc
RHT
+$1.55B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Healthcare 16.96%
3 Financials 13.79%
4 Consumer Discretionary 13.57%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUMU
2476
DELISTED
Qumu Corp.
QUMU
$99K ﹤0.01%
23,750
+300
+1% +$1.01K
AGEN
2477
Agenus
AGEN
$311M
$98K ﹤0.01%
1,669
-2,548
-60% -$139K
ATCO
2478
DELISTED
Atlas Corp.
ATCO
$98K ﹤0.01%
+10,000
New +$96.3K
RRD
2479
DELISTED
RR Donnelley & Sons Co.
RRD
$97K ﹤0.01%
49,255
+100
+0.2% +$330
PZN
2480
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$96K ﹤0.01%
11,232
+100
+0.9% +$905
AVXL icon
2481
Anavex Life Sciences
AVXL
$316M
$95K ﹤0.01%
28,279
+810
+3% +$2.52K
HOV icon
2482
Hovnanian Enterprises
HOV
$793M
$95K ﹤0.01%
+12,547
New +$152K
UEC icon
2483
Uranium Energy
UEC
$5.62B
$94K ﹤0.01%
68,728
+400
+0.6% +$551
IVAC
2484
DELISTED
Intevac Inc
IVAC
$94K ﹤0.01%
19,500
OPCH icon
2485
Option Care Health
OPCH
$3.57B
$90K ﹤0.01%
8,698
+75
+0.9% +$614
CMRX
2486
DELISTED
Chimerix, Inc.
CMRX
$90K ﹤0.01%
20,905
-119,107
-85% -$366K
RBBN icon
2487
Ribbon Communications
RBBN
$372M
$82K ﹤0.01%
16,843
+231
+1% +$1.13K
TWI icon
2488
Titan International
TWI
$450M
$82K ﹤0.01%
16,829
+100
+0.6% +$544
TBHC
2489
DELISTED
The Brand House Collective
TBHC
$80K ﹤0.01%
35,500
-213
-0.6% -$1K
HIVE
2490
DELISTED
Aerohive Networks
HIVE
$80K ﹤0.01%
17,961
+313
+2% +$1.13K
TTPH
2491
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$79K ﹤0.01%
8,180
-43
-0.5% -$791
DWSN icon
2492
Dawson Geophysical
DWSN
$136M
$78K ﹤0.01%
31,349
-343
-1% -$852
LPTH icon
2493
Lightpath Technologies
LPTH
$862M
$78K ﹤0.01%
86,000
GSAT icon
2494
Globalstar
GSAT
$10.8B
$76K ﹤0.01%
10,567
-60
-0.6% -$470
WVVI icon
2495
Willamette Valley Vineyards
WVVI
$11.5M
$75K ﹤0.01%
10,850
NCSM icon
2496
NCS Multistage Holdings
NCSM
$134M
$74K ﹤0.01%
1,038
-45,884
-98% -$3.42M
FRED
2497
DELISTED
Fred's Inc
FRED
$72K ﹤0.01%
146,000
ACRS icon
2498
Aclaris Therapeutics
ACRS
$860M
$68K ﹤0.01%
31,246
+20,800
+199% +$113K
OPTT icon
2499
Ocean Power Technologies
OPTT
$54.1M
$67K ﹤0.01%
+35,195
New +$89.3K
AIOT
2500
PowerFleet Inc
AIOT
$421M
$64K ﹤0.01%
10,800

Similar funds

T. Rowe Price Associates's Q2 2019 Portfolio in Review

As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
  • T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
  • T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
  • T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
  • T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
  • T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.